Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ITGA11
REST API REST API
Homo sapiens
ITGA11 is differentially expressed in 125 experiments: 78 organism parts: bone marrow, cerebellum, ... (76 more);, 58 disease states: normal, glioblastoma, ... (56 more);, 45 cell types 101 cell lines 13 compound treatments and 46 other conditions.
Synonyms HsT18964
Orthologs Itga11 (Mus musculus)   E1C311_CHICK (Gallus gallus)   F1N157_BOVIN (Bos taurus)   Itga11 (Rattus norvegicus)   itga11 (Xenopus laevis)   ITGA11 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term plasma membrane, integrin complex, protein binding, membrane, integrin-mediated signaling pathway, cell adhesion, cell-matrix adhesion, muscle organ development, receptor activity, integral to membrane, collagen binding, substrate-dependent cell migration
InterPro Term VWF_A, Int_alpha_beta-p, FG-GAP, Integrin_alpha-2, Integrin_alpha
UniProt Accession Q9UKX5, F5GZX6, F5H1A1
Search EB-eye ENSG00000137809
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-GEOD-6919, E-TABM-130, ... (15 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-24147, E-GEOD-19480, E-MEXP-980, E-GEOD-4219, ... (14 experiments)

Factor Value U/D Experiments
HT1080
2
E-MTAB-37, E-GEOD-20089
human foreskin fibroblast
1
E-GEOD-4219
MCF7
1
E-MTAB-37
SCH
1
E-GEOD-15460
UT-15
1
E-GEOD-17347
YCC16
1
E-GEOD-15460
95 more value(s).


Cell type

studied in E-GEOD-18811, E-AFMX-5, E-GEOD-20033, E-TABM-130, E-GEOD-1460, ... (22 experiments)

Factor Value U/D Experiments
not specified
1
E-GEOD-18811
PBMCs
1
E-GEOD-20677
squamous cell carcinoma
1
E-GEOD-17347
monocyte
1
E-GEOD-11755
adipose-derived stem cell
1
E-MEXP-1216
chondrocyte
1
E-TABM-130
39 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-MEXP-1121, E-MEXP-2069, E-GEOD-5563, ... (27 experiments)

Factor Value U/D Experiments
glioblastoma
2
E-MTAB-37, E-GEOD-4290
inhalation injury
1
E-GEOD-19743
colon carcinoma
1
E-MTAB-37
invasive ductal carcinoma
1
E-GEOD-8977
adenoma
1
E-GEOD-15960
osteosarcoma
1
E-MTAB-37
52 more value(s).


Compound treatment

studied in E-GEOD-20719, E-GEOD-3284, E-GEOD-5741, E-MEXP-1230, E-TABM-868, ... (9 experiments)

Factor Value U/D Experiments
none
2
3
E-MEXP-1958, E-GEOD-5741, E-GEOD-20719, E-MEXP-1230, E-TABM-868 ... (5 experiments)
unknown
1
E-GEOD-7307
no estradiol
1
E-GEOD-20081
LDL
1
E-GEOD-5741
bacterial endotoxin
1
1
E-GEOD-3284
ethanol
1
E-MEXP-2241
7 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21589

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-19293

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-GEOD-4667

Disease staging
studied in E-GEOD-19743, E-GEOD-22541, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-7578, E-GEOD-20847, E-MEXP-563

Genotype
studied in E-MEXP-421, E-GEOD-17347

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-GEOD-20504, E-GEOD-19018, E-GEOD-9764, E-GEOD-10315

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-1956, E-TABM-666, E-GEOD-19519, ... (14 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-MEXP-561

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Localisation of metastases
studied in E-GEOD-22541

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

Replicate
studied in E-GEOD-10896

RNAi
studied in E-MEXP-2115, E-MEXP-1315, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-4883, E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-GEOD-19246

Tumor grading
studied in E-GEOD-4271

Processing time: 0.431 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM